Ginkgo Bioworks Holdings Inc Class (DNA)
EBITDA Growth
17.39%
TTM · Period ending:
DNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported17.39%period ending
Latest reported17.39%period ending
DNA TTM EBITDA YoY % (-1481.14% → 17.39%)
Year-over-year change
High-resolution chart · PNG
DNA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 17.3941% | |
| 37.1163% | |
| 47.3354% | |
| 47.5573% | |
| 61.08% | |
| 49.5103% | |
| 41.0087% | |
| 3.5777% | |
| 33.6074% | |
| 53.1566% | |
| 60.6845% | |
| 81.6789% | |
| 61.3676% | |
| 29.4085% | |
| -12.6958% | |
| -1,238.5625% | |
| -1,444.8918% | |
| -1,260.8253% | |
| -1,481.1381% |